PT906100E - Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria - Google Patents

Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria

Info

Publication number
PT906100E
PT906100E PT97906125T PT97906125T PT906100E PT 906100 E PT906100 E PT 906100E PT 97906125 T PT97906125 T PT 97906125T PT 97906125 T PT97906125 T PT 97906125T PT 906100 E PT906100 E PT 906100E
Authority
PT
Portugal
Prior art keywords
treatment
affinity
utilization
receptor antagonists
urinary incontinence
Prior art date
Application number
PT97906125T
Other languages
English (en)
Inventor
Rodolfo Testa
Amedeo Leonardi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT906100(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of PT906100E publication Critical patent/PT906100E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Spinning Or Twisting Of Yarns (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97906125T 1996-02-28 1997-02-25 Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria PT906100E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000378A IT1282705B1 (it) 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria

Publications (1)

Publication Number Publication Date
PT906100E true PT906100E (pt) 2004-06-30

Family

ID=11373430

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97906125T PT906100E (pt) 1996-02-28 1997-02-25 Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria

Country Status (10)

Country Link
EP (1) EP0906100B1 (pt)
JP (1) JP2001511763A (pt)
AT (1) ATE258438T1 (pt)
AU (1) AU2093297A (pt)
DE (1) DE69727378T2 (pt)
DK (1) DK0906100T3 (pt)
ES (1) ES2213205T3 (pt)
IT (1) IT1282705B1 (pt)
PT (1) PT906100E (pt)
WO (1) WO1997031637A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
SE510305C2 (sv) 1997-05-30 1999-05-10 Astra Ab Nytt salt
AU8130298A (en) * 1997-07-15 1999-02-10 Sankyo Company Limited Piperazine derivatives
US6906069B1 (en) 1999-01-08 2005-06-14 Amgen Inc. LXR modulators
AU2000235960A1 (en) * 2000-02-14 2001-08-27 Tularik, Inc. Lxr modulators
US6673543B2 (en) 2000-04-05 2004-01-06 Tularik, Inc. Solid phase synthesis of LXR ligands
JP4497814B2 (ja) * 2001-02-16 2010-07-07 アベンティス・ファーマスーティカルズ・インコーポレイテツド 新規複素環式尿素誘導体およびドーパミンｄ３受容体リガンドとしてのそれらの使用
KR20040039436A (ko) * 2001-09-27 2004-05-10 파마시아 에이비 약학 조성물
EP1476425A4 (en) 2002-01-30 2010-05-05 Amgen Inc Heterocyclic Aryl Sulphonamidocyclic Compounds
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
JPWO2006082872A1 (ja) * 2005-02-04 2008-06-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 １−（ピペリジン−４−イル）−１ｈ−インドール誘導体
JP4932717B2 (ja) 2005-05-11 2012-05-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピペリジン環を有するインドール誘導体の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101722A (en) * 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
EP0558245A1 (en) * 1992-02-25 1993-09-01 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
GB9417135D0 (en) * 1994-08-23 1994-10-12 Medinnova S F Method

Also Published As

Publication number Publication date
IT1282705B1 (it) 1998-03-31
ITMI960378A1 (it) 1997-08-28
EP0906100A1 (en) 1999-04-07
DK0906100T3 (da) 2004-05-03
DE69727378D1 (de) 2004-03-04
DE69727378T2 (de) 2004-12-09
WO1997031637A1 (en) 1997-09-04
AU2093297A (en) 1997-09-16
JP2001511763A (ja) 2001-08-14
ES2213205T3 (es) 2004-08-16
ITMI960378A0 (pt) 1996-02-28
EP0906100B1 (en) 2004-01-28
ATE258438T1 (de) 2004-02-15

Similar Documents

Publication Publication Date Title
PT906100E (pt) Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria
EA199800340A1 (ru) Производные пиримидина как антагонисты 5нт2с
AU9648098A (en) Adenosine a3 receptor antagonists
ATE234290T1 (de) Phenylalkyl-imidazole als h3-rezeptor- antagonisten
BR1100680A (pt) Antagonistas tricìclos de receptores de 5-ht3
CZ352196A3 (en) Heterocyclic compounds exhibiting antagonistic activity on tachykinin receptor, their preparation and use
LV11688A (lv) Morfolina tahikinina receptoru antagonistu priekstecvielas
ES2162676T3 (es) Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3.
ATE219764T1 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
EP1762236A3 (en) Formulations of alpha adrenergic receptor antagonists and their uses
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
ES2195943T3 (es) Compuestos heteroaromaticos biciclicos y triciclicos.
CA2133106A1 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
BR9910144A (pt) Antagonistas de receptores de quimiocinas e seu uso
NO20012194D0 (no) CRF-reseptorantagonister og tilhörende fremgangsmåter
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
BR0010802A (pt) Antagonistas de receptor il-8
FI960571A (fi) Kolekystokiniini- ja gastriiniantagonisteina käyttökelpoisia bisyklo(2.2.2)oktaanijohdannaisia
FR2702150B1 (fr) Application de dérivés de 2H-1,2-4-benzothiadiazine-3(4H)-one-1,1-dioxyde comme antagonistes non compétitifs du récepteur NMDA.
IT1255461B (it) Eteri di imidazoli ad attivita' a ii antagonista
AU2001263329A1 (en) Crf receptor antagonists and methods relating thereto
DE59408441D1 (de) Substituierte 1-Phenyl-oxazolidin-2-on Derivate, deren Herstellung und deren Verwendung als Adhäsionsrezeptor-Antagonisten
BR9915641A (pt) Benzil lactobionamidas como inibidores de proliferação de células de músculo liso
IT1270611B (it) Derivati eterociclo-condensati di morfinoidi